Cue Biopharma, Inc.
CUE
$0.84
$0.02182.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -6.88% | -65.76% | -52.07% | -40.72% | -48.13% |
| Total Receivables | -71.20% | -- | -44.35% | 89.77% | 62.73% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 16.11% | -15.94% | -15.71% | 44.55% | 5.91% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -9.01% | -64.34% | -51.14% | -35.23% | -44.37% |
|
|
|||||
| Total Current Assets | -9.01% | -64.34% | -51.14% | -35.23% | -44.37% |
| Net Property, Plant & Equipment | 1.73% | -35.01% | -31.99% | -43.33% | -39.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 45.36% | -25.18% | -25.22% | -9.15% | -9.17% |
| Total Assets | -3.83% | -58.75% | -47.68% | -34.95% | -42.14% |
|
|
|||||
| Total Accounts Payable | -7.14% | -3.44% | -19.37% | 161.05% | 65.79% |
| Total Accrued Expenses | -66.73% | -18.78% | -29.71% | -37.60% | 11.92% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -35.42% | -3.12% | 7.39% | -6.85% | -4.27% |
| Total Finance Division Other Current Liabilities | 881.45% | -70.11% | -95.98% | -88.43% | -61.68% |
| Total Other Current Liabilities | 881.45% | -70.11% | -95.98% | -88.43% | -61.68% |
| Total Current Liabilities | 16.98% | -14.33% | -19.86% | -2.42% | 0.93% |
|
|
|||||
| Total Current Liabilities | 16.98% | -14.33% | -19.86% | -2.42% | 0.93% |
| Long-Term Debt | -- | -- | -- | -74.26% | -62.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 58.21% | -93.18% | -68.28% | -65.60% | -57.33% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.89% | -34.45% | -39.90% | -25.85% | -23.76% |
|
|
|||||
| Common Stock & APIC | 10.26% | 4.98% | 6.23% | 8.27% | 6.99% |
| Retained Earnings | -12.02% | -12.94% | -13.50% | -15.50% | -16.97% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -16.02% | -78.09% | -52.81% | -40.55% | -53.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -16.02% | -78.09% | -52.81% | -40.55% | -53.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -16.02% | -78.09% | -52.81% | -40.55% | -53.00% |
|
|
|||||